BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis-Reference-Cited by-同舟云学术

BCL2 super-expressor diffuse large B-cell lymphoma: a distinct subgroup associated with poor prognosis

Published:2021-11-11 Issue: Volume: Page:
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Roh Jin,Cho Hyungwoo,Pak Hyo-Kyung,Lee Yoon Sei,Lee Sang-wook,Ryu Jin-Sook,Chae Eun Jin,Kim Kyung Won,Huh Jooryung,Choi Yoon Seok,Jeong Seong Hyun,Suh Cheolwon,Yoon Dok Hyun,Park Chan-Sik

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00962-z.pdf

Reference46 articles.

1. Coiffier, B. et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N. Engl J Med 346, 235–242 (2002).

2. Vitolo, U. et al. Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large B-cell lymphoma. J Clin Oncol 35, 3529–3537 (2017).

3. Crump, M. et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood 130, 1800–1808 (2017).

4. Alizadeh, A. A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511 (2000).

5. Rosenwald, A. et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N. Engl J Med 346, 1937–1947 (2002).

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana;Biomedicines;2024-01-25

2. Cancer Resistance Is Mediated by the Upregulation of Several Anti-Apoptotic Gene Products via the Inducible Nitric Oxide Synthase/Nitric Oxide Pathway: Therapeutic Implications;Antioxidants & Redox Signaling;2023-11-01

3. Ubiquitin-proteasome pathway mediated regulation of Bcl-2 family: effects and therapeutic approaches;Haematologica;2023-08-16

4. High BECN1 Expression Negatively Correlates with BCL2 Expression and Predicts Better Prognosis in Diffuse Large B-Cell Lymphoma: Role of Autophagy;Cells;2023-07-25

5. The role of comorbidity indices and histochemical markers in surgically resected and non-resected primary central nervous system lymphoma;Clinical and Experimental Medicine;2023-07-25